1. Home
  2. PCRX vs ARI Comparison

PCRX vs ARI Comparison

Compare PCRX & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.70

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

BUY

Current Price

$6.23

Market Cap

884.4M

Sector

Real Estate

ML Signal

BUY

Company Overview

Basic Information
Metric
PCRX
ARI
Founded
2006
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
884.4M
IPO Year
2010
2009

Fundamental Metrics

Financial Performance
Metric
PCRX
ARI
Price
$24.70
$6.23
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
★ $30.00
$8.00
AVG Volume (30 Days)
468.1K
★ 2.6M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 16.05%
EPS Growth
107.44
★ 183.51
EPS
0.19
★ 0.27
Revenue
★ $541,533,000.00
$271,589,000.00
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.69
N/A
P/E Ratio
$132.47
★ $23.07
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$6.11
52 Week High
$27.66
$11.24

Technical Indicators

Market Signals
Indicator
PCRX
ARI
Relative Strength Index (RSI) 46.61 30.61
Support Level $24.61 N/A
Resistance Level $25.17 $7.00
Average True Range (ATR) 0.77 0.11
MACD 0.00 0.02
Stochastic Oscillator 42.46 30.79

Price Performance

Historical Comparison
PCRX
ARI

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: